ESMO 2025
Leading Melanoma Institute Australia clinicians and researchers are in Europe to share latest research findings and clinical updates with international colleagues as we continue our efforts to reach zero deaths from melanoma.
Adjuvant vs Neoadjuvant – Further evidence for pre-surgery immunotherapy
Results of the RELATIVITY-098 clinical trial published in Nature Medicine show the presence of tumour is directly related to the effectiveness of combination immunotherapy for high risk and advanced melanoma, providing more evidence that neoadjuvant immunotherapy is the new frontier in treatment for melanoma, and other cancers.
Vikki Steel
Vikki Steel is the Clinical Research Associate Team Leader in the Investigator Led Clinical Trials team at Melanoma Institute Australia. Learn about her professional journey and her life outside of work here!
Dr Esther Lim
Esther Lim is a Cancer & Immune Cell Biologist at Melanoma Institute Australia, based at Macquarie University. Read more about her latest research and personal life!
Inspired fundraising by our dedicated community
Our inspiring community has been busy hosting and participating in varied events all to support MIA - from gourmet dinners, golf days, running challenges and events held to honour loved ones.
Shafayat Chowdhury
Shafayat Chowdhury is a Clinical Biospecimen Coordinator at Melanoma Institute Australia (MIA). Read on for Shafayat's Q&A.